ResMed (RMD)
(Delayed Data from NYSE)
$203.15 USD
-0.73 (-0.36%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $203.00 -0.15 (-0.07%) 7:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC8/1/24 |
---|---|
Current Quarter | 2.02 |
EPS Last Quarter | 2.13 |
Last EPS Surprise | 10.94% |
ABR | 1.96 |
Earnings ESP
|
-3.35% |
---|---|
Current Year | 7.70 |
Next Year | 8.72 |
EPS (TTM) | 7.25 |
P/E (F1) | 23.29 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.21B | 1.18B | 4.66B | 4.99B |
# of Estimates | 6 | 4 | 6 | 6 |
High Estimate | 1.23B | 1.19B | 4.69B | 5.07B |
Low Estimate | 1.19B | 1.18B | 4.62B | 4.90B |
Year ago Sales | 1.12B | 1.10B | 4.22B | 4.66B |
Year over Year Growth Est. | 7.49% | 7.18% | 10.46% | 6.99% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.02 | 2.03 | 7.70 | 8.72 |
# of Estimates | 4 | 3 | 5 | 5 |
Most Recent Consensus | 1.95 | 1.97 | 7.60 | 8.28 |
High Estimate | 2.11 | 2.09 | 7.76 | 9.21 |
Low Estimate | 1.95 | 1.97 | 7.60 | 8.28 |
Year ago EPS | 1.60 | 1.64 | 6.44 | 7.70 |
Year over Year Growth Est. | 26.25% | 23.78% | 19.57% | 13.27% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 2 |
Up Last 60 Days | 1 | 1 | 1 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 2 | 1 |
Down Last 60 Days | 0 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Current | 2.02 | 2.03 | 7.70 | 8.72 |
7 Days Ago | 2.02 | 2.03 | 7.70 | 8.72 |
30 Days Ago | 2.02 | 2.02 | 7.70 | 8.72 |
60 Days Ago | 2.02 | 2.02 | 7.70 | 8.72 |
90 Days Ago | 1.97 | 1.96 | 7.45 | 8.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (6/2024) |
Next Year (6/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.95 | 1.97 | 7.70 | 8.77 |
Zacks Consensus Estimate | 2.02 | 2.03 | 7.70 | 8.72 |
Earnings ESP | -3.35% | -2.80% | 0.04% | 0.51% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 2.13 | 1.88 | 1.64 | 1.60 | NA |
Estimate | 1.92 | 1.81 | 1.63 | 1.67 | NA |
Difference | 0.21 | 0.07 | 0.01 | -0.07 | 0.06 |
Surprise | 10.94% | 3.87% | 0.61% | -4.19% | 2.81% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more